Taymour Hammoudi, MD, PhD

Assistant Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation


FacultyPhoto
Medical School
  • MD, Emory University School of Medicine (2014)
Graduate Schools
  • PhD, Emory University (2014)
  • PhD, Georgia Institute Of Technology (2014)
Undergraduate School
  • BS, North Carolina State University (NC) (2005)
Residency
  • University of California (San Francisco) School of Medicine Program, Pediatrics (2017)
Fellowships
  • University of California (San Francisco) School of Medicine Program, Pediatric Hematology / Oncology (2021)
  • Duke University Hospital Program, Pediatric Transplantation and Cellular Therapy (2023)
Languages
English
Department
Pediatrics-Heme/Onc and Bone Marrow Transplantation

Professional Titles

  • Assistant Professor

Research Interests

My clinical interests are in leveraging patients' existing or transplanted immune system to treat pediatric and young adult cancers. This dovetails with my research interests, which are primarily focused on: (1) profiling and understanding the immune microenvironment of pediatric malignancies; and (2) improving our understanding of how we harness, optimize and drive an augmented immune system after transplant to treat cancer.

Publications

  • Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB, Cai C, Zhan J, Davis KC, Kelley RK, Chapman JS, Atreya CE, Patel A, Daud AI, Ha P, Diaz AA, Kratz JR, Collisson EA, Fragiadakis GK, Erle DJ, Boissonnas A, Asthana S, Chan V, Krummel MF. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. 2022 Jan 6;185(1):184-203.e19. PubMed PMID: 34963056
  • Rinker TE, Hammoudi TM, Kemp ML, Lu H, Temenoff JS. Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment. Integr Biol (Camb). 2014 Mar;6(3):324-37. PubMed PMID: 24463781
  • Hamilton SK, Bloodworth NC, Massad CS, Hammoudi TM, Suri S, Yang PJ, Lu H, Temenoff JS. Development of 3D hydrogel culture systems with on-demand cell separation. Biotechnol J. 2013 Apr;8(4):485-95. PubMed PMID: 23447378
  • Hammoudi TM, Rivet CA, Kemp ML, Lu H, Temenoff JS. Three-dimensional in vitro tri-culture platform to investigate effects of crosstalk between mesenchymal stem cells, osteoblasts, and adipocytes. Tissue Eng Part A. 2012 Aug;18(15-16):1686-97. PubMed PMID: 22472084
  • Lim JJ, Hammoudi TM, Bratt-Leal AM, Hamilton SK, Kepple KL, Bloodworth NC, McDevitt TC, Temenoff JS. Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. Acta Biomater. 2011 Mar;7(3):986-95. PubMed PMID: 20965281
  • Hammoudi TM, Lu H, Temenoff JS. Long-term spatially defined coculture within three-dimensional photopatterned hydrogels. Tissue Eng Part C Methods. 2010 Dec;16(6):1621-8. PubMed PMID: 20412031
  • Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB, Cai C, Zhan J, Davis KC, Kelley RK, Chapman JS, Atreya CE, Patel A, Daud AI, Ha P, Diaz AA, Kratz JR, Collisson EA, Fragiadakis GK, Erle DJ, Boissonnas A, Asthana S, Chan V, Krummel MF. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. 2022 Jan 6;185(1):184-203.e19. PubMed PMID: 34963056
  • Lim JJ, Hammoudi TM, Bratt-Leal AM, Hamilton SK, Kepple KL, Bloodworth NC, McDevitt TC, Temenoff JS. Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. Acta Biomater. 2011 Mar;7(3):986-95. PubMed PMID: 20965281
  • Hammoudi TM, Lu H, Temenoff JS. Long-term spatially defined coculture within three-dimensional photopatterned hydrogels. Tissue Eng Part C Methods. 2010 Dec;16(6):1621-8. PubMed PMID: 20412031
  • Hammoudi TM, Rivet CA, Kemp ML, Lu H, Temenoff JS. Three-dimensional in vitro tri-culture platform to investigate effects of crosstalk between mesenchymal stem cells, osteoblasts, and adipocytes. Tissue Eng Part A. 2012 Aug;18(15-16):1686-97. PubMed PMID: 22472084
  • Hamilton SK, Bloodworth NC, Massad CS, Hammoudi TM, Suri S, Yang PJ, Lu H, Temenoff JS. Development of 3D hydrogel culture systems with on-demand cell separation. Biotechnol J. 2013 Apr;8(4):485-95. PubMed PMID: 23447378
  • Rinker TE, Hammoudi TM, Kemp ML, Lu H, Temenoff JS. Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment. Integr Biol (Camb). 2014 Mar;6(3):324-37. PubMed PMID: 24463781
  • Hammoudi, Taymour M., and Johnna S. Temenoff. Biomaterials for regeneration of tendons and ligaments. Springer Vienna, 2011.
  • Hammoudi, Taymour Marwan. 3D micropatternable hydrogel systems to examine crosstalk effects between mesenchymal stem cells, osteoblasts, and adipocytes. Diss. Georgia Institute of Technology, 2012.
  • Lim JJ, Hammoudi TM, Bratt-Leal AM, Hamilton SK, Kepple KL, Bloodworth NC, McDevitt TC, Temenoff JS. Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. Acta Biomater. 2011 Mar;7(3):986-95. PubMed PMID: 20965281
  • Hammoudi TM, Lu H, Temenoff JS. Long-term spatially defined coculture within three-dimensional photopatterned hydrogels. Tissue Eng Part C Methods. 2010 Dec;16(6):1621-8. PubMed PMID: 20412031
  • Hammoudi TM, Rivet CA, Kemp ML, Lu H, Temenoff JS. Three-dimensional in vitro tri-culture platform to investigate effects of crosstalk between mesenchymal stem cells, osteoblasts, and adipocytes. Tissue Eng Part A. 2012 Aug;18(15-16):1686-97. PubMed PMID: 22472084
  • Hamilton SK, Bloodworth NC, Massad CS, Hammoudi TM, Suri S, Yang PJ, Lu H, Temenoff JS. Development of 3D hydrogel culture systems with on-demand cell separation. Biotechnol J. 2013 Apr;8(4):485-95. PubMed PMID: 23447378
  • Rinker TE, Hammoudi TM, Kemp ML, Lu H, Temenoff JS. Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment. Integr Biol (Camb). 2014 Mar;6(3):324-37. PubMed PMID: 24463781
  • Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB, Cai C, Zhan J, Davis KC, Kelley RK, Chapman JS, Atreya CE, Patel A, Daud AI, Ha P, Diaz AA, Kratz JR, Collisson EA, Fragiadakis GK, Erle DJ, Boissonnas A, Asthana S, Chan V, Krummel MF. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. 2022 Jan 6;185(1):184-203.e19. PubMed PMID: 34963056

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

Specialties
  • Pediatrics, Board Certification (2019)
  • Pediatric Hematology / Oncology, Board Certification (2021)
  • Physician License, Colorado Medical Board, License (2023)
  • Physician License, New Mexico Medical Board, License (2024)
Conditions & Treatments
  • Cancers - Blood and Marrow Transplant
  • Cancers
  • Cancers - Cancer Medicine
  • Cancers - Pediatric Cancer
Clinical Interests
My clinical interests are in providing comprehensive care through transplant and therapy to treat cancer in children and young adults.

Care Philosophy
I believe in empowering patients and caregivers by treating them as a whole, providing maximal information possible, leaving no questions unanswered, and adhering to values of honesty, integrity, and humility. I will be fully engaged with you and your caregivers to provide the best possible care.

Personal Interests
In my spare time, I enjoy hiking, kayaking, camping, snowshoeing and other ways to explore the great outdoors. I also enjoy international travel, culinary exploration, and jazz music.